Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biologics and Biosimilars Market Research Report 2018

  • QYR2806961
  • 126 Pages
  • November 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 

This report studies the global Biologics and Biosimilars market status and forecast, categorizes the global Biologics and Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report

Pfizer

Roche

Amgen

AbbVie

Sanofi

Johnson & Johnson

Novo Nordisk

Novartis

Merck

Lilly

3sbio

Changchun High Tech

CP Guojian Pharmacy

Biotech Pharma

Gelgen Biopharma

Sandoz

Teva

Hospira

Mylan

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

Southeast Asia

India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Antibiotic

Enzyme

Hormone

Non-Patented Biological Reagents

Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Tumor

Diabetes

Cardiovascular

Hemophilia

Other

The study objectives of this report are:

To analyze and study the global Biologics and Biosimilars capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

Focuses on the key Biologics and Biosimilars manufacturers, to study the capacity, production, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics and Biosimilars are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Biologics and Biosimilars Manufacturers

Biologics and Biosimilars Distributors/Traders/Wholesalers

Biologics and Biosimilars Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Biologics and Biosimilars market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Biologics and Biosimilars Market Research Report 2018

1 Biologics and Biosimilars Market Overview

1.1 Product Overview and Scope of Biologics and Biosimilars

1.2 Biologics and Biosimilars Segment by Type (Product Category)

1.2.1 Global Biologics and Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)

1.2.2 Global Biologics and Biosimilars Production Market Share by Type (Product Category) in 2017

1.2.3 Antibiotic

1.2.3 Enzyme

1.2.5 Hormone

1.2.6 Non-Patented Biological Reagents

Other

1.3 Global Biologics and Biosimilars Segment by Application

1.3.1 Biologics and Biosimilars Consumption (Sales) Comparison by Application (2013-2025)

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Global Biologics and Biosimilars Market by Region (2013-2025)

1.4.1 Global Biologics and Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)

1.4.2 North America Status and Prospect (2013-2025)

1.4.3 Europe Status and Prospect (2013-2025)

1.4.4 China Status and Prospect (2013-2025)

1.4.5 Japan Status and Prospect (2013-2025)

1.4.6 Southeast Asia Status and Prospect (2013-2025)

1.4.7 India Status and Prospect (2013-2025)

1.5 Global Market Size (Value) of Biologics and Biosimilars (2013-2025)

1.5.1 Global Biologics and Biosimilars Revenue Status and Outlook (2013-2025)

1.5.2 Global Biologics and Biosimilars Capacity, Production Status and Outlook (2013-2025)

2 Global Biologics and Biosimilars Market Competition by Manufacturers

2.1 Global Biologics and Biosimilars Capacity, Production and Share by Manufacturers (2013-2018)

2.1.1 Global Biologics and Biosimilars Capacity and Share by Manufacturers (2013-2018)

2.1.2 Global Biologics and Biosimilars Production and Share by Manufacturers (2013-2018)

2.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2013-2018)

2.3 Global Biologics and Biosimilars Average Price by Manufacturers (2013-2018)

2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area and Product Type

2.5 Biologics and Biosimilars Market Competitive Situation and Trends

2.5.1 Biologics and Biosimilars Market Concentration Rate

2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Biologics and Biosimilars Capacity, Production, Revenue (Value) by Region (2013-2018)

3.1 Global Biologics and Biosimilars Capacity and Market Share by Region (2013-2018)

3.2 Global Biologics and Biosimilars Production and Market Share by Region (2013-2018)

3.3 Global Biologics and Biosimilars Revenue (Value) and Market Share by Region (2013-2018)

3.4 Global Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.5 North America Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.6 Europe Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.7 China Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.8 Japan Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.9 Southeast Asia Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.10 India Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Biologics and Biosimilars Supply (Production), Consumption, Export, Import by Region (2013-2018)

4.1 Global Biologics and Biosimilars Consumption by Region (2013-2018)

4.2 North America Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

4.3 Europe Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

4.4 China Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

4.5 Japan Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

4.6 Southeast Asia Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

4.7 India Biologics and Biosimilars Production, Consumption, Export, Import (2013-2018)

5 Global Biologics and Biosimilars Production, Revenue (Value), Price Trend by Type

5.1 Global Biologics and Biosimilars Production and Market Share by Type (2013-2018)

5.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)

5.3 Global Biologics and Biosimilars Price by Type (2013-2018)

5.4 Global Biologics and Biosimilars Production Growth by Type (2013-2018)

6 Global Biologics and Biosimilars Market Analysis by Application

6.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2013-2018)

6.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Biologics and Biosimilars Manufacturers Profiles/Analysis

7.1 Pfizer

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Biologics and Biosimilars Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Pfizer Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.1.4 Main Business/Business Overview

7.2 Roche

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Biologics and Biosimilars Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Roche Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.2.4 Main Business/Business Overview

7.3 Amgen

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Biologics and Biosimilars Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Amgen Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.3.4 Main Business/Business Overview

7.4 AbbVie

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Biologics and Biosimilars Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 AbbVie Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.4.4 Main Business/Business Overview

7.5 Sanofi

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Biologics and Biosimilars Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Sanofi Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015-2018)

7.5.4 Main Business/Business Overview

7.6 Johnson & Johnson

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Biologics and Biosimilars Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Johnson & Johnson Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.6.4 Main Business/Business Overview

7.7 Novo Nordisk

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Biologics and Biosimilars Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Novo Nordisk Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.7.4 Main Business/Business Overview

7.8 Novartis

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Biologics and Biosimilars Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Novartis Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.8.4 Main Business/Business Overview

7.9 Merck

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Biologics and Biosimilars Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Merck Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.9.4 Main Business/Business Overview

7.8 Lilly

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Biologics and Biosimilars Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Lilly Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.10.4 Main Business/Business Overview

7.11 3sbio

7.12 Changchun High Tech

7.13 CP Guojian Pharmacy

7.14 Biotech Pharma

7.15 Gelgen Biopharma

7.16 Sandoz

7.17 Teva

7.18 Hospira

7.19 Mylan

8 Biologics and Biosimilars Manufacturing Cost Analysis

8.1 Biologics and Biosimilars Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Biologics and Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Biologics and Biosimilars Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Biologics and Biosimilars Market Forecast (2018-2025)

12.1 Global Biologics and Biosimilars Capacity, Production, Revenue Forecast (2018-2025)

12.1.1 Global Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2018-2025)

12.1.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2018-2025)

12.1.3 Global Biologics and Biosimilars Price and Trend Forecast (2018-2025)

12.2 Global Biologics and Biosimilars Production, Consumption , Import and Export Forecast by Region (2018-2025)

12.2.1 North America Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.2 Europe Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.3 China Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.4 Japan Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.5 Southeast Asia Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.6 India Biologics and Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.3 Global Biologics and Biosimilars Production, Revenue and Price Forecast by Type (2018-2025)

12.4 Global Biologics and Biosimilars Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

List of Tables and Figures

Figure Picture of Biologics and Biosimilars

Figure Global Biologics and Biosimilars Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Biologics and Biosimilars Production Market Share by Types (Product Category) in 2017

Figure Product Picture of Antibiotic

Table Major Manufacturers of Antibiotic

Figure Product Picture of Enzyme

Table Major Manufacturers of Enzyme

Figure Product Picture of Hormone

Table Major Manufacturers of Hormone

Figure Product Picture of Non-Patented Biological Reagents

Table Major Manufacturers of Non-Patented Biological Reagents

Figure Product Picture of Other

Table Major Manufacturers of Other

Figure Global Biologics and Biosimilars Consumption (K Units) by Applications (2013-2025)

Figure Tumor Examples

Table Key Downstream Customer in Tumor

Figure Diabetes Examples

Table Key Downstream Customer in Diabetes

Figure Cardiovascular Examples

Table Key Downstream Customer in Cardiovascular

Figure Hemophilia Examples

Table Key Downstream Customer in Hemophilia

Figure Other Examples

Table Key Downstream Customer in Other

Figure Global Biologics and Biosimilars Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)

Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)

Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)

Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)

Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Biologics and Biosimilars Revenue (Million USD) Status and Outlook (2013-2025)

Figure Global Biologics and Biosimilars Capacity, Production (K Units) Status and Outlook (2013-2025)

Figure Global Biologics and Biosimilars Major Players Product Capacity (K Units) (2013-2018)

Table Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers (2013-2018)

Table Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2013-2018)

Figure Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers in 2017

Figure Global Biologics and Biosimilars Capacity (K Units) of Key Manufacturers in 2018

Figure Global Biologics and Biosimilars Major Players Product Production (K Units) (2013-2018)

Table Global Biologics and Biosimilars Production (K Units) of Key Manufacturers (2013-2018)

Table Global Biologics and Biosimilars Production Share by Manufacturers (2013-2018)

Figure 2017 Biologics and Biosimilars Production Share by Manufacturers

Figure 2017 Biologics and Biosimilars Production Share by Manufacturers

Figure Global Biologics and Biosimilars Major Players Product Revenue (Million USD) (2013-2018)

Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2013-2018)

Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2013-2018)

Table 2017 Global Biologics and Biosimilars Revenue Share by Manufacturers

Table 2018 Global Biologics and Biosimilars Revenue Share by Manufacturers

Table Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers (2013-2018)

Figure Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2017

Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area

Table Manufacturers Biologics and Biosimilars Product Category

Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers

Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers

Table Global Biologics and Biosimilars Capacity (K Units) by Region (2013-2018)

Figure Global Biologics and Biosimilars Capacity Market Share by Region (2013-2018)

Figure Global Biologics and Biosimilars Capacity Market Share by Region (2013-2018)

Figure 2017 Global Biologics and Biosimilars Capacity Market Share by Region

Table Global Biologics and Biosimilars Production by Region (2013-2018)

Figure Global Biologics and Biosimilars Production (K Units) by Region (2013-2018)

Figure Global Biologics and Biosimilars Production Market Share by Region (2013-2018)

Figure 2017 Global Biologics and Biosimilars Production Market Share by Region

Table Global Biologics and Biosimilars Revenue (Million USD) by Region (2013-2018)

Table Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)

Figure Global Biologics and Biosimilars Revenue Market Share by Region (2013-2018)

Table 2017 Global Biologics and Biosimilars Revenue Market Share by Region

Figure Global Biologics and Biosimilars Capacity, Production (K Units) and Growth Rate (2013-2018)

Table Global Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table North America Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Europe Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table China Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Japan Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Southeast Asia Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table India Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Global Biologics and Biosimilars Consumption (K Units) Market by Region (2013-2018)

Table Global Biologics and Biosimilars Consumption Market Share by Region (2013-2018)

Figure Global Biologics and Biosimilars Consumption Market Share by Region (2013-2018)

Figure 2017 Global Biologics and Biosimilars Consumption (K Units) Market Share by Region

Table North America Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)

Table Europe Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)

Table China Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)

Table Japan Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)

Table Southeast Asia Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)

Table India Biologics and Biosimilars Production, Consumption, Import & Export (K Units) (2013-2018)

Table Global Biologics and Biosimilars Production (K Units) by Type (2013-2018)

Table Global Biologics and Biosimilars Production Share by Type (2013-2018)

Figure Production Market Share of Biologics and Biosimilars by Type (2013-2018)

Figure 2017 Production Market Share of Biologics and Biosimilars by Type

Table Global Biologics and Biosimilars Revenue (Million USD) by Type (2013-2018)

Table Global Biologics and Biosimilars Revenue Share by Type (2013-2018)

Figure Production Revenue Share of Biologics and Biosimilars by Type (2013-2018)

Figure 2017 Revenue Market Share of Biologics and Biosimilars by Type

Table Global Biologics and Biosimilars Price (USD/Unit) by Type (2013-2018)

Figure Global Biologics and Biosimilars Production Growth by Type (2013-2018)

Table Global Biologics and Biosimilars Consumption (K Units) by Application (2013-2018)

Table Global Biologics and Biosimilars Consumption Market Share by Application (2013-2018)

Figure Global Biologics and Biosimilars Consumption Market Share by Applications (2013-2018)

Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2017

Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)

Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2013-2018)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Pfizer Biologics and Biosimilars Production Market Share (2013-2018)

Figure Pfizer Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Roche Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Roche Biologics and Biosimilars Production Market Share (2013-2018)

Figure Roche Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Amgen Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Amgen Biologics and Biosimilars Production Market Share (2013-2018)

Figure Amgen Biologics and Biosimilars Revenue Market Share (2013-2018)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure AbbVie Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure AbbVie Biologics and Biosimilars Production Market Share (2013-2018)

Figure AbbVie Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sanofi Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Sanofi Biologics and Biosimilars Production Market Share (2013-2018)

Figure Sanofi Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Johnson & Johnson Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Johnson & Johnson Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Johnson & Johnson Biologics and Biosimilars Production Market Share (2013-2018)

Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Novo Nordisk Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Novo Nordisk Biologics and Biosimilars Production Market Share (2013-2018)

Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Novartis Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Novartis Biologics and Biosimilars Production Market Share (2013-2018)

Figure Novartis Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Merck Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Merck Biologics and Biosimilars Production Market Share (2013-2018)

Figure Merck Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lilly Biologics and Biosimilars Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Lilly Biologics and Biosimilars Production Growth Rate (2013-2018)

Figure Lilly Biologics and Biosimilars Production Market Share (2013-2018)

Figure Lilly Biologics and Biosimilars Revenue Market Share (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biologics and Biosimilars

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Figure Biologics and Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017

Table Major Buyers of Biologics and Biosimilars

Table Distributors/Traders List

Figure Global Biologics and Biosimilars Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Global Biologics and Biosimilars Price (Million USD) and Trend Forecast (2018-2025)

Table Global Biologics and Biosimilars Production (K Units) Forecast by Region (2018-2025)

Figure Global Biologics and Biosimilars Production Market Share Forecast by Region (2018-2025)

Table Global Biologics and Biosimilars Consumption (K Units) Forecast by Region (2018-2025)

Figure Global Biologics and Biosimilars Consumption Market Share Forecast by Region (2018-2025)

Figure North America Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)

Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table North America Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Asia-Pacific Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Asia-Pacific Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Asia-Pacific Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Europe Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Europe Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Central & South America Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Central & South America Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Central & South America Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Southeast Asia Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Southeast Asia Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure India Biologics and Biosimilars Production (K Units) and Growth Rate Forecast (2018-2025)

Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table India Biologics and Biosimilars Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Table Global Biologics and Biosimilars Production (K Units) Forecast by Type (2018-2025)

Figure Global Biologics and Biosimilars Production (K Units) Forecast by Type (2018-2025)

Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2018-2025)

Table Global Biologics and Biosimilars Price Forecast by Type (2018-2025)

Table Global Biologics and Biosimilars Consumption (K Units) Forecast by Application (2018-2025)

Figure Global Biologics and Biosimilars Consumption (K Units) Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370